DIX Daniel B.,DIX Daniel B.,TANG Xiaolin,TANG Xiaolin
申请号:
SI201131568
公开号:
SI2624865T1
申请日:
2011.10.05
申请国别(地区):
SI
年份:
2018
代理人:
摘要:
The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-4 receptor (hIL-4R). The formulations may contain, in addition to an anti-hIL-4R antibody, at least one amino acid, at least one sugar, or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.